Full Text View
Tabular View
No Study Results Posted
Related Studies
Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra (RBT)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Harriet Shezi Children's Clinic.
Recruitment status was  Recruiting
Study NCT01259219   Information provided by Harriet Shezi Children's Clinic

First Received on December 13, 2010.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Mycobutin
Additional drug interventions recognized in this trial
Rifabutin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antitubercular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Harriet Shezi Children's Clinic


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services